Oct 29, 2025
On World Psoriasis Day, the European Health and Digital Executive Agency (HaDEA) highlights how the iPROLEPSIS project is advancing early detection and personalised care for psoriatic arthritis
Psoriatic arthritis (PsA) is a chronic inflammatory condition that can cause irreversible joint damage if left undiagnosed or untreated. To address this challenge, iPROLEPSIS is developing AI-driven predictive models and digital tools that help identify individuals at risk, enable earlier diagnosis, and support more personalised treatment pathways.
In a recent interview with Prof. Leontios Hadjileontiadis, project coordinator, HaDEA explores how iPROLEPSIS brings together clinicians, researchers, and data scientists to transform psoriatic arthritis management across Europe.
The discussion covers the project’s use of AI and biological data to build comprehensive patient profiles, its collaborative approach between dermatology and rheumatology, and the importance of EU funding and ethical, cross-border cooperation in enabling innovation.
Read the full article on HaDEA’s website: https://hadea.ec.europa.eu/news/world-psoriasis-day-exploration-how-horizon-europe-project-improving-early-detection-psoriatic-2025-10-29_en
